Subcutaneous Drug Delivery Devices Market Share and Forecast by 2027

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027

Subcutaneous Drug Delivery Devices Market to 2027 - Global Analysis and Forecasts by Technology (Syringes, Pens, Patches, Others); Syringe Type (Prefilled Injectable, Filled Injectable); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

  • Report Date : Sep 2019
  • Report Code : TIPRE00006411
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 157

The subcutaneous drug delivery devices market was valued at US$ 9,243.80 million in 2018 and it is projected to reach US$ 17,290.47 million in 2027; it is expected to grow at a CAGR of 7.4% from 2019 to 2027.

Subcutaneous drug delivery refers to a process that involves administration of medication or medicine under the skin. In the subcutaneous drug delivery process, a small needle is used to inject the drug in the tissue present in between muscle and skin. The drug is usually injected in low volumes, which varies between 1 mL to 2mL. For instance, insulin is widely administered through subcutaneous injection. The abdomen, arm, and thigh are the most common injection sites for subcutaneous injection. The growth of the global subcutaneous drug delivery devices market is attributed to the increased number of chronic disease, increasing R&D expenditures in pharmaceutical and medical device companies and technological advancements and increasing product launches. However, risk of infections and other diseases associated with the use of injections and syringes is the major factor hindering the market growth.

The global subcutaneous drug delivery devices market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years. 

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Subcutaneous Drug Delivery Devices Market: Strategic Insights

subcutaneous-drug-delivery-devices-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights

Increasing R&D Expenditures in Pharmaceutical and Medical Device Companies to Drive Global Subcutaneous Drug Delivery Devices Market Growth

Research and development (R&D) is an essential and crucial part of the company’s business. Pharmaceutical and medical devices companies focus on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market.

R&D spending by the biopharmaceutical companies has also increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion 2012 to US$ 58.8 billion in 2015. Also, Evonik Corporation has invested more than $50 million over the last 4 years to advance its competencies in medical devices, and production of RESOMER polymers for drug delivery and bio reabsorbable medical devices.

Thus the growing R&D expenditure drives the subcutaneous drug delivery systems market during the forecast period.

Technology -Based Insights

In terms of technology, the global subcutaneous drug delivery devices market is segmented into syringes, pens, patches and others. In 2018, the syringes segment held largest share of the market. However, the patches segment is estimated to grow at the fastest rate during the forecast period.

Syringe Type-Based Insights

In terms of syringe type, the global subcutaneous drug delivery devices market is segmented into prefilled injectable and fillable injectable. In 2018, the fillable injectable segment held largest share of the market. However, the prefilled injectable segment is expected to register the highest CAGR during the forecast period.

Subcutaneous Drug Delivery Devices Market Regional Insights

The regional trends and factors influencing the Subcutaneous Drug Delivery Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Subcutaneous Drug Delivery Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

subcutaneous-drug-delivery-devices-market-global-geography
  • Get the Regional Specific Data for Subcutaneous Drug Delivery Devices Market

Subcutaneous Drug Delivery Devices Market Report Scope

Report Attribute Details
Market size in 2018 US$ 9.24 Billion
Market Size by 2027 US$ 17.29 Billion
Global CAGR (2018 - 2027) 7.4%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Technology
  • Syringes
  • Pens
  • Patches
By Syringe Type
  • Prefilled Injectable
  • Filled Injectable
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Insulet Corporation
  • BD
  • Enable Injections
  • Consort Medical Plc
  • West Pharmaceutical Services, Inc.
  • Elcam Medical
  • Amgen
  • Ypsomed AG
  • SCPharmaceuticals, Inc.

  • Subcutaneous Drug Delivery Devices Market Players Density: Understanding Its Impact on Business Dynamics

    The Subcutaneous Drug Delivery Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Subcutaneous Drug Delivery Devices Market are:

    1. Insulet Corporation
    2. BD
    3. Enable Injections
    4. Consort Medical Plc
    5. West Pharmaceutical Services, Inc.

    Disclaimer: The companies listed above are not ranked in any particular order.


    subcutaneous-drug-delivery-devices-market-cagr

    • Get the Subcutaneous Drug Delivery Devices Market top key players overview

    Distribution Channel-Based Insights

    In terms of distribution channel, the global subcutaneous drug delivery devices market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the market in 2018, and the same segment is estimated to grow at the fastest rate during the forecast period.

    The global subcutaneous drug delivery devices market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

    Global Subcutaneous Drug Delivery Devices Market – by Technology

    • Syringes
    • Pens
    • Patches
    • Others  

    Global Subcutaneous Drug Delivery Devices Market – by Syringe Type

    • Prefilled Injectable
    • Fillable Injectable

    Global Subcutaneous Drug Delivery Devices Market – by Distribution Channel

    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies

    Global Subcutaneous Drug Delivery Devices Market – by Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East & Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South America and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of SCAM

     

    Company Profiles

    • Insulet Corporation
    • BD
    • Enable Injections
    • Consort Medical Plc
    • West Pharmaceutical Services, Inc.
    • Elcam Medical
    • Amgen
    • Ypsomed AG
    • SCPharmaceuticals, Inc.
    • Wilhelm Haselmeier GmbH & Co. KG
    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Subcutaneous Drug Delivery Devices Market

    1. Insulet Corporation
    2. BD
    3. Enable Injections
    4. Consort Medical Plc
    5. West Pharmaceutical Services, Inc.
    6. Elcam Medical
    7. Amgen
    8. Ypsomed AG
    9. SCPharmaceuticals, Inc.
    10. Wilhelm Haselmeier GmbH & Co. KG
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo